Abstract
Governments are considering financial incentives to increase vaccine uptake to end the COVID-19 pandemic. Incentives being offered include cash-equivalents such as vouchers or being entered into lotteries. Our experiment involved random assignment of 1,628 unvaccinated participants in the United States to one of three 45 second informational videos promoting vaccination with messages about: (a) health benefits of COVID-19 vaccines (control); (b) being entered into lotteries; or (c) receiving cash equivalent vouchers. After seeing the control health information video, 16% of individuals wanted information on where to get vaccinated. This compared with 14% of those assigned to the lottery video (odds ratio of 0.82 relative to control: 95% credible interval 0.57-1.17) and 22% of those assigned to the cash voucher video (odds ratio of 1.53 relative to control: 95% credible interval 1.11-2.11). These results support greater use of cash vouchers to promote COVID-19 vaccine uptake and do not support the use of lottery incentives.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Pre-registered at OSF:osf.io/adrw3
Clinical Protocols
Funding Statement
Computational resources and services used in this work were provided by the High Performance Computer and Research Support Group, Queensland University of Technology, Brisbane, Australia. We acknowledge the generous funding of Nuffield College for these experiments. Raymond Duch acknowledges the support provided by FONDECYT 2020 grant number 1201397. Philip Clarke, Laurence Roope and Mara Violato were partly supported by National Institute for Health Research BRC grant (University of Oxford [NIHR-BRC-1215-20008])
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The survey was conducted according to the University of Oxfords policy for human participants research and approved by the University of Oxford Medical Sciences Inter-divisional Research Ethics Committee (MS IDREC) (Approval ID: R72328/RE001). Informed consent was obtained from each participant at the beginning of the survey.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
* Computational resources and services used in this work were provided by the High Performance Computer and Research Support Group, Queensland University of Technology, Brisbane, Australia. We acknowledge the generous funding of Nuffield College for these experiments. Raymond Duch acknowledges the support provided by FONDECYT 2020 grant number 1201397. Philip Clarke, Laurence Roope and Mara Violato were partly supported by National Institute for Health Research BRC grant (University of Oxford [NIHR-BRC-1215-20008]) Online Supplemental Materials are available at https://github.com/CANDOUR-COVID/US-Vaccine-Incentive. Replications files and data from this project will be made available at https://dataverse.harvard.edu/dataverse/VaccineIncentives
Data Availability
Replications files and data from this project will be made available at the time of publication in a peer-review journal from https://dataverse.harvard.edu/dataverse/VaccineIncentives
Data Availability
Replications files and data from this project will be made available at the time of publication in a peer-review journal from https://dataverse.harvard.edu/dataverse/VaccineIncentives
